Sign in

CIK 0001553643

  • Non-accelerated filer
  • Smaller reporting company

RELMADA THERAPEUTICS, INC.

Sign in to watch
Ticker
RLMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
455401931
Phone
+1 646-876-3459
Business address
2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
Former names
CAMP NINE, INC.
Open-market buys, last 90 days
$1,671,990
in 2 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$1,671,990. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Shenouda Maged +$844K Chief Financial Officer 1 filing
  2. TRAVERSA SERGIO +$828K Chief Executive Officer 1 filing
Date Insider Transaction Shares Price Value Owned after
2019-10-18 Kelly Paul Edward Director Purchase +400 $19.07 $8K 123,621
2019-10-18 Kelly Paul Edward Director Purchase +100 $19.08 $2K 123,721
2019-10-18 Kelly Paul Edward Director Purchase +200 $19.10 $4K 123,921
2019-10-18 Kelly Paul Edward Director Purchase +100 $19.15 $2K 124,021
2019-10-18 Kelly Paul Edward Director Purchase +3,100 $19.20 $60K 127,121
2019-07-29 Vitolo Ottavio V. Chief Medical Officer Grant or award · Options to purchase common stock +150,000 $2.20 $330K 150,000
2019-07-29 Shenouda Maged Director Grant or award · Options to purchase common stock +500,000 $2.20 $1.1M 500,000
2019-07-29 Kelly Paul Edward Director Grant or award · Options to purchase common stock +600,000 $2.20 $1.3M 600,000
2019-07-29 CASAMENTO CHARLES J Director Grant or award · Options to purchase common stock +500,000 $2.20 $1.1M 500,000
2019-07-29 TRAVERSA SERGIO Chief Executive Officer Grant or award · Options to purchase common stock +1,700,000 $2.20 $3.7M 1,700,000
2019-05-14 Kelly Paul Edward Director Purchase +100,000 $1.50 $150K 488,483
2019-05-14 Kelly Paul Edward Director Purchase · Warrant +50,000 $2.25 $113K 50,000
2018-12-20 Vitolo Ottavio V. Chief Medical Officer Grant or award · Options to purchase common stock +400,000 $1.15 $460K 400,000
2018-12-20 TRAVERSA SERGIO Chief Executive Officer Grant or award · Options to purchase common stock +900,000 $1.15 $1.0M 900,000
2018-12-20 Shenouda Maged Director Grant or award · Options to purchase common stock +450,000 $1.15 $518K 450,000
2018-12-20 Kelly Paul Edward Director Grant or award · Options to purchase common stock +500,000 $1.15 $575K 500,000
2018-12-20 CASAMENTO CHARLES J Director Grant or award · Options to purchase common stock +450,000 $1.15 $518K 450,000
2018-12-11 Kelly Paul Edward Director Purchase +5,000 $1.21 $6K 388,483
2018-10-18 Kelly Paul Edward Director Conversion +223,483 $0.72 $161K 383,483
2018-10-12 Kelly Paul Edward Director Purchase +150,000 $0.90 $135K 160,000

Page 16 of 19 · 370 trades